Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Aclaris Therapeutics
ACRS
$743M
| $287K | ﹤0.01% |
260,706
-158,628
| -38% | -$186K |
|
3377
Compass Therapeutics
CMPX
$349M
| $286K | ﹤0.01% |
286,191
+45,996
| +19% | +$67.2K |
|
|
VCSA
3378
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $286K | ﹤0.01% |
58,640
+37,973
| +184% | +$209K |
|
|
GATO
3379
DELISTED
Gatos Silver, Inc.
GATO
| $286K | ﹤0.01% |
27,350
+9,452
| +53% | +$99.9K |
|
3380
EVI Industries
EVI
$188M
| $283K | ﹤0.01% |
14,980
-2,445
| -14% | -$50.8K |
|
|
EGRX
3381
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $283K | ﹤0.01% |
50,589
-23,338
| -32% | -$102K |
|
|
ALIM
3382
DELISTED
Alimera Sciences
ALIM
| $280K | ﹤0.01% |
+50,431
| New | +$179K |
|
3383
XBiotech
XBIT
$68.3M
| $278K | ﹤0.01% |
54,139
+43,662
| +417% | +$337K |
|
3384
HF Foods Group
HFFG
$80.2M
| $278K | ﹤0.01% |
92,601
| – | – |
|
3385
Q32 Bio
QTTB
$462M
| $277K | ﹤0.01% |
+15,410
| New | +$369K |
|
3386
Stereotaxis
STXS
$133M
| $276K | ﹤0.01% |
151,806
+129,110
| +569% | +$290K |
|
3387
Neuropace
NPCE
$469M
| $276K | ﹤0.01% |
+36,537
| New | +$369K |
|
3388
Gyre Therapeutics
GYRE
$648M
| $275K | ﹤0.01% |
+23,091
| New | +$317K |
|
|
MPX
3389
DELISTED
Marine Products Corp
MPX
| $275K | ﹤0.01% |
27,248
+2,855
| +12% | +$30.7K |
|
3390
Southland Holdings
SLND
$29.4M
| $275K | ﹤0.01% |
59,953
+970
| +2% | +$4.78K |
|
3391
Quantum-Si Incorporated
QSI
$157M
| $273K | ﹤0.01% |
260,442
-1,033
| -0.4% | -$1.66K |
|
3392
iShares Morningstar Mid-Cap ETF
IMCB
$1.66B
| $269K | ﹤0.01% |
+3,831
| New | +$270K |
|
3393
Endava
DAVA
$153M
| $267K | ﹤0.01% |
+9,145
| New | +$271K |
|
3394
Sonida Senior Living
SNDA
$1.9B
| $265K | ﹤0.01% |
+9,650
| New | +$281K |
|
3395
The ONE Group
STKS
$56.5M
| $265K | ﹤0.01% |
62,298
+38
| +0.1% | +$197 |
|
3396
Tilly's
TLYS
$113M
| $264K | ﹤0.01% |
43,727
-17,182
| -28% | -$99.5K |
|
3397
Acumen Pharmaceuticals
ABOS
$157M
| $263K | ﹤0.01% |
+108,743
| New | +$346K |
|
3398
D-Wave Quantum Inc. Common Stock
QBTS
$6.66B
| $262K | ﹤0.01% |
229,563
+206,253
| +885% | +$291K |
|
3399
Magnachip Semiconductor
MX
$116M
| $261K | ﹤0.01% |
+53,610
| New | +$270K |
|
3400
Veru
VERU
$35.6M
| $261K | ﹤0.01% |
+31,025
| New | +$359K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.